These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 22001556)

  • 1. Development and validation of a cell-based SEAP reporter assay for the detection of neutralizing antibodies against an anti-IL-13 therapeutic antibody.
    Liao K; Sikkema D; Wang C; Chen K; DeWall S; Lee TN
    J Immunol Methods; 2012 Jan; 375(1-2):258-63. PubMed ID: 22001556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and optimization of a cell-based neutralizing antibody assay using a sample pre-treatment step to eliminate serum interference.
    McCutcheon KM; Quarmby V; Song A
    J Immunol Methods; 2010 Jun; 358(1-2):35-45. PubMed ID: 20361968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an enzymatic assay for the detection of neutralizing antibodies against therapeutic angiotensin-converting enzyme 2 (ACE2).
    Liao K; Sikkema D; Wang C; Lee TN
    J Immunol Methods; 2013 Mar; 389(1-2):52-60. PubMed ID: 23298658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a generic immunoassay with drug tolerance to detect immune complexes in serum samples from cynomolgus monkeys after administration of human antibodies.
    Stubenrauch K; Wessels U; Essig U; Vogel R; Schleypen J
    J Pharm Biomed Anal; 2010 Jun; 52(2):249-54. PubMed ID: 20083366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a cell-based bioassay for the detection of neutralizing antibodies against recombinant human erythropoietin in clinical studies.
    Wei X; Swanson SJ; Gupta S
    J Immunol Methods; 2004 Oct; 293(1-2):115-26. PubMed ID: 15541282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical validation of a highly sensitive microparticle-based immunoassay for the quantitation of IL-13 in human serum using the Erenna immunoassay system.
    St Ledger K; Agee SJ; Kasaian MT; Forlow SB; Durn BL; Minyard J; Lu QA; Todd J; Vesterqvist O; Burczynski ME
    J Immunol Methods; 2009 Oct; 350(1-2):161-70. PubMed ID: 19732777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of design of experiments (DOE) in the development and validation of a cell-based bioassay for the detection of anti-drug neutralizing antibodies in human serum.
    Chen XC; Zhou L; Gupta S; Civoli F
    J Immunol Methods; 2012 Feb; 376(1-2):32-45. PubMed ID: 22119514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of a pre-treatment procedure to eliminate human monoclonal antibody therapeutic drug and matrix interference in cell-based functional neutralizing antibody assays.
    Xu W; Jiang H; Titsch C; Haulenbeek JR; Pillutla RC; Aubry AF; DeSilva BS; Arnold ME; Zeng J; Dodge RW
    J Immunol Methods; 2015 Jan; 416():94-104. PubMed ID: 25445325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates.
    Stubenrauch K; Wessels U; Lenz H
    J Pharm Biomed Anal; 2009 May; 49(4):1003-8. PubMed ID: 19250787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and elimination of target-related matrix interference in a neutralizing anti-drug antibody assay.
    Schwickart M; Mehrzai F; Pearson J; Shaghasi N; Chavez C; Schneider A; Wu S; Roskos L; Liang M
    J Immunol Methods; 2014 Jan; 403(1-2):52-61. PubMed ID: 24287421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of a Quasi-Quantitative Bioassay for Neutralizing Antibodies Against CP-870,893.
    Baltrukonis DJ; Finco-Kent D; Kawabata TT; Poirier M; Lesauteur L
    J Immunotoxicol; 2006 Sep; 3(3):157-64. PubMed ID: 18958696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies.
    Fournier C; Duverlie G; François C; Schnuriger A; Dedeurwaerder S; Brochot E; Capron D; Wychowski C; Thibault V; Castelain S
    Virol J; 2007 Mar; 4():35. PubMed ID: 17397531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of anti-ESA antibodies in human samples from PRCA and non-PRCA patients: an immunoassay platform comparison.
    Barger TE; Kuck AJ; Chirmule N; Swanson SJ; Mytych DT
    Nephrol Dial Transplant; 2012 Feb; 27(2):688-93. PubMed ID: 21602184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of cell-based luciferase reporter gene assays for measuring neutralizing anti-drug antibodies against interferon beta.
    Hermanrud C; Ryner M; Luft T; Jensen PE; Ingenhoven K; Rat D; Deisenhammer F; Sørensen PS; Pallardy M; Sikkema D; Bertotti E; Kramer D; Creeke P; Fogdell-Hahn A;
    J Immunol Methods; 2016 Mar; 430():1-9. PubMed ID: 26779831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel homogeneous Biotin-digoxigenin based assay for the detection of human anti-therapeutic antibodies in autoimmune serum.
    Qiu ZJ; Ying Y; Fox M; Peng K; Lewin-Koh SC; Coleman D; Good J; Lowe J; Rahman A; Yang J; Jiang J; Quarmby V; Song A
    J Immunol Methods; 2010 Oct; 362(1-2):101-11. PubMed ID: 20868690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of interleukin-13-mediated cell activation by a novel inhibitory antibody to human IL-13 receptor alpha1.
    Krause S; Behrends J; Borowski A; Lohrmann J; Lang S; Myrtek D; Lorenzen T; Virchow JC; Luttmann W; Friedrich K
    Mol Immunol; 2006 Apr; 43(11):1799-807. PubMed ID: 16364441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of low-affinity anti-drug antibodies and improved drug tolerance in immunogenicity testing by Octet(®) biolayer interferometry.
    Li J; Schantz A; Schwegler M; Shankar G
    J Pharm Biomed Anal; 2011 Jan; 54(2):286-94. PubMed ID: 20869832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of human anti-idiotypic antibodies by phage display for clinical immune response assays.
    Tornetta M; Fisher D; O'Neil K; Geng D; Schantz A; Brigham-Burke M; Lombardo D; Fink D; Knight D; Sweet R; Tsui P
    J Immunol Methods; 2007 Dec; 328(1-2):34-44. PubMed ID: 17888945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Neutralizing Antibody Assay Based on a Reporter of Antibody-Dependent Cell-Mediated Cytotoxicity.
    Wu Y; Li JJ; Kim HJ; Liu X; Liu W; Akhgar A; Bowen MA; Spitz S; Jiang XR; Roskos LK; White WI
    AAPS J; 2015 Nov; 17(6):1417-26. PubMed ID: 26205082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cell-based and non-cell-based assay platforms for the detection of clinically relevant anti-drug neutralizing antibodies for immunogenicity assessment of therapeutic proteins.
    Hu J; Wala I; Han H; Nagatani J; Barger T; Civoli F; Kaliyaperumal A; Zhuang Y; Gupta S
    J Immunol Methods; 2015 Apr; 419():1-8. PubMed ID: 25795420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.